Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Penumbra Inc (PEN)
Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,790,239
  • Shares Outstanding, K 38,596
  • Annual Sales, $ 847,130 K
  • Annual Income, $ -2,000 K
  • 60-Month Beta 0.62
  • Price/Sales 10.38
  • Price/Cash Flow 281.72
  • Price/Book 7.96
Trade PEN with:

Options Overview Details

View History
  • Implied Volatility 38.89% ( +0.83%)
  • Historical Volatility 53.23%
  • IV Percentile 45%
  • IV Rank 31.06%
  • IV High 62.42% on 10/12/23
  • IV Low 28.30% on 06/16/23
  • Put/Call Vol Ratio 0.28
  • Today's Volume 23
  • Volume Avg (30-Day) 1,198
  • Put/Call OI Ratio 1.19
  • Today's Open Interest 20,286
  • Open Int (30-Day) 20,597

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.71
  • Number of Estimates 7
  • High Estimate 0.87
  • Low Estimate 0.58
  • Prior Year 0.16
  • Growth Rate Est. (year over year) +343.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
180.93 +25.80%
on 11/10/23
236.49 -3.75%
on 11/24/23
+29.75 (+15.04%)
since 11/03/23
3-Month
180.93 +25.80%
on 11/10/23
302.00 -24.63%
on 09/11/23
-36.51 (-13.82%)
since 09/01/23
52-Week
180.93 +25.80%
on 11/10/23
348.67 -34.72%
on 06/30/23
+16.76 (+7.95%)
since 12/02/22

Most Recent Stories

More News
Penumbra: Q3 Earnings Snapshot

Penumbra: Q3 Earnings Snapshot

PEN : 227.49 (-0.11%)
Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2023 after...

PEN : 227.49 (-0.11%)
Penumbra, Inc. to Present at Upcoming Investor Conferences

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates...

PEN : 227.49 (-0.11%)
Penumbra: Q2 Earnings Snapshot

Penumbra: Q2 Earnings Snapshot

PEN : 227.49 (-0.11%)
Penumbra, Inc. Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second...

PEN : 227.49 (-0.11%)
Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 43rd Annual Growth...

PEN : 227.49 (-0.11%)
Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2023 after...

PEN : 227.49 (-0.11%)
Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair's 43rd Annual Growth Stock...

PEN : 227.49 (-0.11%)
Syneos Health (SYNH) Announces a $7.1 Billion Merger Agreement

Syneos Health (SYNH) is set to become private company following a $7.1 billion merger deal to be acquired by a private investment consortium.

SYNH : 42.98 (+0.02%)
AXDX : 4.20 (-2.10%)
PEN : 227.49 (-0.11%)
SIBN : 19.06 (+1.28%)
Walgreens Boots (WBA) New Alliances Aid Growth, Cost Woe Stays

Intensifying competition in the U.S. pharmacy retail drugstore market compels Walgreens Boots (WBA) to diversify its product offerings through new partnerships.

WBA : 20.55 (-1.15%)
AXDX : 4.20 (-2.10%)
PEN : 227.49 (-0.11%)
SIBN : 19.06 (+1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 239.97
2nd Resistance Point 234.83
1st Resistance Point 231.29
Last Price 227.49
1st Support Level 222.61
2nd Support Level 217.47
3rd Support Level 213.93

See More

52-Week High 348.67
Fibonacci 61.8% 284.59
Fibonacci 50% 264.80
Fibonacci 38.2% 245.01
Last Price 227.49
52-Week Low 180.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar